Iovance Biotherapeutics
IOVA
#6119
Rank
โ‚ฌ0.80 B
Marketcap
2,02ย โ‚ฌ
Share price
-2.25%
Change (1 day)
-63.90%
Change (1 year)

Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: โ‚ฌ0.80 Billion

As of February 2026 Iovance Biotherapeutics has a market cap of โ‚ฌ0.80 Billion. This makes Iovance Biotherapeutics the world's 6119th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Iovance Biotherapeutics from 2010 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.80 B-16.67%
2025โ‚ฌ0.96 B-55.38%
2024โ‚ฌ2.15 B14.69%
2023โ‚ฌ1.88 B100.22%
2022โ‚ฌ0.94 B-64.46%
2021โ‚ฌ2.64 B-52.21%
2020โ‚ฌ5.53 B77.16%
2019โ‚ฌ3.12 B227.16%
2018โ‚ฌ0.95 B97.15%
2017โ‚ฌ0.48 B17.83%
2016โ‚ฌ0.41 B19.9%
2015โ‚ฌ0.34 B56.95%
2014โ‚ฌ0.21 B43.45%
2013โ‚ฌ0.15 B1023.57%
2012โ‚ฌ13.55 M-77.72%
2011โ‚ฌ60.82 M-8.44%
2010โ‚ฌ66.43 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Iovance Biotherapeutics was reported to be:

โ‚ฌ0.82 Billion
by Nasdaq info icon info icon
โ‚ฌ0.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
โ‚ฌ15.47 M-98.07% Bahamas
NRC Health
NRC
โ‚ฌ0.30 B-61.83%๐Ÿ‡บ๐Ÿ‡ธ USA